Preferred Label : Pseudohypoaldosteronism, type iid;
Symbol : PHA2D;
CISMeF acronym : FHHT; PHA2D;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : FHHT; Familial hyperkalemic hypertension;
Description : Familial hyperkalemic hypertension, also known as type II pseudohypoaldosteronism
(PHAII) or Gordon syndrome, is a rare autosomal dominant disease in which a net positive
sodium ion balance is associated with renal potassium ion retention, resulting in
hypertension, hyperkalemia, and hyperchloremic metabolic acidosis (summary by Louis-Dit-Picard
et al., 2012). - Genetic Heterogeneity of Type II Pseudohypoaldosteronism For a discussion
of genetic heterogeneity of type II pseudohypoaldosteronism, see PHA2A (145260).;
Inheritance : Autosomal dominant; Autosomal recessive;
Molecular basis : Caused by mutation in the kelch-like 3 gene (KLHL3, 605775.0001);
Laboratory abnormalities : Hyperkalemia ( 6.2 mM in both dominant and recessive); Hyperchloremia (mean 110 mM in both dominant and recessive);
Prefixed ID : #614495;
Origin ID : 614495;
UMLS CUI : C3469605;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)